title: Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for tamoxifen pharmacogenetic studies.
authors: Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL (JAJ, ISH, TYL). johnson@cop.ufl.edu.
authors: Julie A
authors: JA
authors: Johnson
authors: Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL (JAJ, ISH, TYL).
authors: Issam S
authors: IS
authors: Hamadeh
authors: Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL (JAJ, ISH, TYL).
authors: Taimour Y
authors: TY
authors: Langaee
mesh_terms: D000328:Adult; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000517:prevention & control; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D004334:Drug Administration Schedule; D005260:Female; D005557:Formaldehyde; D005838:Genotype; D006801:Humans; D019656:Loss of Heterozygosity; D008875:Middle Aged; D016612:Paraffin Embedding; D011322:Primary Prevention / Q000379:methods; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use*; D013629:Tamoxifen / Q000494:pharmacology / Q000627:therapeutic use*; D016707:Tissue Fixation
chemical_list: D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D005557:Formaldehyde; D019389:Cytochrome P-450 CYP2D6